MONICA GAD: Open Payments
NPI 1770002362 · METUCHEN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,294 in 105 payments from 33 companies in 2025. Trend: 2023 $1,131 · 2024 $1,136 · 2025 $2,294
Food & beverage: $2,195Education: $99
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 15 | $234 |
| PFIZER INC. | 9 | $216 |
| Janssen Biotech, Inc. | 12 | $201 |
| Novartis Pharmaceuticals Corporation | 10 | $179 |
| Daiichi Sankyo Inc. | 5 | $171 |
| Syndax Pharmaceuticals, Inc. | 2 | $169 |
| ABBVIE INC. | 10 | $152 |
| AstraZeneca Pharmaceuticals LP | 4 | $94 |
| Regeneron Healthcare Solutions, Inc. | 3 | $86 |
| Sumitomo Pharma America, Inc. | 3 | $83 |
Products named: REVUFORJ, Enhertu, SHINGRIX, IBRANCE, KISQALI, ERLEADA, VENCLEXTA, LIBTAYO.
Industry payments across NJ — which companies pay providers there.
